Abpro Bio Co., Ltd. (KOSDAQ: 195990)

Market Cap	126.40B
Revenue (ttm)	18.58B
Net Income (ttm)	-20.16B
Shares Out	284.69M
EPS (ttm)	-71.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	211,719
Open	447.00
Previous Close	445.00
Day's Range	443.00 - 454.00
52-Week Range	395.00 - 940.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Abpro Bio

Abpro Bio Co., Ltd. engages in the manufacture and sale of various machine tools in South Korea and internationally. Its products include tapping, spindle machine, machining, and turning center, as well as machining center with long table. The company was founded in 1991 and is headquartered in Daegu, South Korea.

• Industry: Metalworking Machinery And Equipment
• Founded: 1991
• Employees: 51
• Stock Exchange: KOSDAQ
• Ticker Symbol: 195990

Financial Performance

In 2023, Abpro Bio's revenue was 25.38 billion, an increase of 14.76% compared to the previous year's 22.11 billion. Losses were -25.74 billion, 216.1% more than in 2022.